Development of a Novel IGF2BP1 Inhibitor as Metastasis-Specific Therapeutic Agent

A. Singh, V. Singh, N. Wallis, O. Elimelech, F. Oberman, A. Ramos, J. Yisraeli, V. Spiegelman, A. Sharma

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
Pages (from-to)S104-S105
JournalEuropean Journal of Cancer
Volume174
DOIs
StatePublished - Oct 2022

Cite this